medigraphic.com
SPANISH

Acta Médica Grupo Angeles

Órgano Oficial del Hospital Angeles Health System
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
    • Send manuscript
    • Names and affiliations of the Editorial Board
  • Policies
  • About us
    • Data sharing policy
    • Stated aims and scope
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2021, Number 1

<< Back Next >>

Acta Med 2021; 19 (1)

What are the risks of COVID-19 dispersion in Mexico?

Peña RJC
Full text How to cite this article 10.35366/98594

DOI

DOI: 10.35366/98594
URL: https://dx.doi.org/10.35366/98594

Language: Spanish
References: 11
Page: 151-156
PDF size: 197.83 Kb.


Key words:

COVID-19, dispersion, Flügge droplets, contagion, household, indoor, environment.

ABSTRACT

In this essay, we present factors that favors the dispersion of the virus COVID-19 in the community and the risks for the mobility specially in the big cities. We analyzed the number of viral particles expelled by subjects: contaminated, asymptomatic, pre-symptomatic and symptomatic during conversation, sneeze, cough and normal breathing. Inhale 1,000 particles of the virus is sufficient to get an infection. With just a cough or a sneeze, a person infected can expel more than 200 million particles to the environment. If that happens in a closed facility (home, room, office), the possibility of infection rises exponentially. The use of a mask is highly recommended in all situations. The opening to activities in many cities, was followed by a rebound in the dispersion of the virus. It is advisable to avoid a premature opening, before a significant and sustained decrease occurred in the number of cases and deaths in the community.


REFERENCES

  1. Chertorivsky S, Córdova JA, Frenk J, Juan M, Narro J, Soberón G. La gestión de la pandemia en México. Análisis preliminar y recomendaciones. México: Consejo Consultivo Ciudadano Pensando en México; 2020. pp. 11-131.

  2. Grupo Reforma Especial COVID-19 en México. Actualizado al 25/11/2020. Publicado en su página electrónica del 26 de noviembre 2020.

  3. Wilkinson-Ryan T. Our minds aren't equipped for this kind of reopening. The Atlantic. 6 de julio de 2020.

  4. Morawska L, Milton DK. It is time to address airborne transmission of coronavirus disease 2019 (COVID-19). Clin Infect Dis. 2020; 71 (9): 2311-2313.

  5. 5 Salas J, Mariano Z. Radiografía de tres brotes: así se contagiaron y así podemos evitarlo. El País. 8 de junio de 2020. Disponible en: https://elpais.com/ciencia/2020-06-06/radiografia-de-tres-brotes-asi-se-contagiaron-y-asi-podemos-evitarlo.html

  6. Gandhi M, Yokoe DS, Havlir DV. Asymptomatic transmission, the Achilles' heel of current strategies to control COVID-19. N Engl J Med. 2020; 382 (22): 2158-2160.

  7. DOF: 23/03/2020, ACUERDO por el que el Consejo de Salubridad General reconoce la epidemia de enfermedad por el virus SARS-CoV-2 (COVID-19) en México, como una enfermedad grave de atención prioritaria, así como se establecen las actividades de preparación y respuesta ante dicha epidemia. Disponible en: http://dof.gob.mx/notaDetalle.phpcodigo=5590161&fecha=23/03/2020

  8. MacIntyre CR, Chughtai AA. A rapid systematic review of the efficacy of face masks and respirators against coronaviruses and other respiratory transmissible viruses for the community, healthcare workers and sick patients. Int J Nurs Stud. 2020; 108: 103629. Available in: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7191274/

  9. Zhanga R, Li Y, Zhang AL, Wang Y, Molina MJ. Identificando la transmisión aérea como la ruta dominante para la propagación del COVID-19. Science of the Total Environment. 2020. Disponible en: https://centromariomolina.org/wp-content/uploads/2020/06/Espa%C3%B1ol_3o-COVID-Zhang-MM_fin.pdf

  10. Zhu J, Ji P, Pang J, Zhong Z, Li H, He C et al. Clinical characteristics of 3062 COVID-19 patients: a meta-analysis. J Med Virol. 2020; 92 (10): 1902-1914. doi: 10.1002/jmv.25884.

  11. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020; 382 (18): 1708-1720.




Figure 1

2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Acta Med. 2021;19